Zobrazeno 1 - 10
of 35
pro vyhledávání: '"P. Eric Konicki"'
Publikováno v:
Journal of Gambling Issues. :225-232
Gambling disorder (GD) is associated with a higher prevalence of adverse childhood experiences (ACEs). Whether this applies to groups such as U.S. veterans, who already have elevated ACEs, is not known. In this pilot study, we extracted ACEs from the
Autor:
P Eric Konicki, Kamal Gandotra, Kingman P. Strohl, George E. Jaskiw, Carl Rosenberg, Brigid Wilson
Publikováno v:
Sleep. 42
Autor:
Elizabeth M. Oliva, Corey S. Davis, Matthew McCaa, Michael F. Cochran, Eleanor T. Lewis, Andrea Nevedal, Christine M. Wilder, P. Eric Konicki
Publikováno v:
Substance Abuse. 37:118-126
Background In an effort to prevent opioid overdose mortality among Veterans, Department of Veterans Affairs (VA) facilities began implementing opioid overdose education and naloxone distribution (OEND) in 2013 and a national program began in 2014. VA
Publikováno v:
Journal of Clinical Psychopharmacology. 39:281-282
Autor:
Matthew A. Fuller, Mary C. Borovicka, George E. Jaskiw, Vickie Steele, P. Eric Konicki, John White
Publikováno v:
The Journal of Clinical Psychiatry. 63:345-348
Background Weight gain is a common side effect of clozapine treatment and may expose patients to obesity-associated health risks. We proposed that concomitant treatment with an appetite suppressant such as phenylpropanolamine (PPA) would lead to a de
Autor:
Kong Kwon, George E. Jaskiw, Martha Sajatovic, Luis F. Ramirez, George Jurjus, P. Eric Konicki
Publikováno v:
International Journal of Geriatric Psychiatry. 12:553-558
Objective. The objective was to analyze outcome of clozapine therapy in elderly patients with treatment refractory primary psychosis. Design. This was an open-label clozapine trial in elderly patients. Patient psychopathology was assessed before and
Publikováno v:
Life Sciences. 48:1411-1416
The short-term effects of fluphenazine on plasma HVA concentrations were compared with the effects of fluphenazine and concurrent administration of debrisoquin, a monoamine oxidase inhibitor which does not cross the blood brain barrier and is used to
Publikováno v:
Psychiatric services (Washington, D.C.). 55(4)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.